$155 Million is the total value of POPE ASSET MANAGEMENT, LLC's 44 reported holdings in Q1 2017. The portfolio turnover from Q4 2016 to Q1 2017 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| Sell | DNB Nor Asa Ord Shs | $27,347,000 | +6.1% | 1,727,802 | -0.4% | 17.62% | -7.7% | |
| COP | Sell | Conocophillips Nfs Llc Is | $5,095,000 | -1.5% | 102,179 | -0.9% | 3.28% | -14.2% |
| TTE | Sell | Total Fina SA ADR | $2,469,000 | -85.4% | 48,981 | -85.3% | 1.59% | -87.3% |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
- Capital Strategies Advisors, Inc. #1
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2017-05-25
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Conocophillips Nfs Llc Is | 19 | Q3 2018 | 16.9% |
| China Ritar Power Corp | 19 | Q3 2018 | 6.1% |
| Tianyin Pharmaceutical Co Inc | 19 | Q3 2018 | 5.6% |
| Liandi Clean Technology Inc Co | 19 | Q3 2018 | 1.6% |
| China Sky One Med Inc Com | 19 | Q3 2018 | 1.5% |
| Exxon Mobil Corporation | 19 | Q3 2018 | 0.5% |
| Chevrontexaco Corp | 19 | Q3 2018 | 0.5% |
| Jiangbo Pharmaceuticals Inc | 19 | Q3 2018 | 0.1% |
| Total Fina SA ADR | 18 | Q3 2018 | 43.7% |
| China Pharma Hldgs Inc Com | 18 | Q4 2017 | 1.0% |
View POPE ASSET MANAGEMENT, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| China Housing & Land Development, Inc. | February 17, 2016 | 928,215 | 13.2% |
| CHINA YIDA HOLDING, CO. | February 17, 2016 | 678,713 | 17.3% |
| TIANYIN PHARMACEUTICAL CO., INC. | February 17, 2016 | 745,175 | 2.5% |
| LianDi Clean Technology Inc. | February 19, 2013 | 2,361,368 | 6.5% |
| CHINA PHARMA HOLDINGS, INC. | February 14, 2013 | 52,823 | 0.1% |
| Shengtai Pharmaceutical, Inc. | February 14, 2013 | 1,412,500 | 14.7% |
| CHINA SKY ONE MEDICAL, INC. | February 17, 2012 | 1,164,422 | 6.9% |
| Jiangbo Pharmaceuticals, Inc. | February 17, 2012 | 744,696 | 5.4% |
| Benda Pharmaceutical, Inc. | February 15, 2012 | 22,337,998 | 21.2% |
| China Ritar Power Corp. | February 15, 2012 | 7,173,994 | 32.8% |
View POPE ASSET MANAGEMENT, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2018-11-30 |
| 13F-HR | 2018-02-23 |
| 13F-HR | 2017-11-22 |
| 13F-HR | 2017-08-28 |
| 13F-HR | 2017-05-25 |
| 13F-HR | 2017-03-01 |
| 13F-HR | 2016-11-18 |
| 13F-HR | 2016-05-17 |
| 13F-HR | 2016-02-17 |
| SC 13G | 2016-02-17 |
View POPE ASSET MANAGEMENT, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.